Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Involvement of CDA and/or dCK Metabolizing Enzymes in the Response to Azacytidine Treatment of Patients With Hematologic Malignancies

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT06886425
Title field or adapter rule
{'original_value': 'Involvement of CDA and/or dCK Metabolizing Enzymes in the Response to Azacytidine Treatment of Patients With Hematologic Malignancies', 'source_field': 'protocolSection.identificationModule.officialTitle'}
Ingested At
2026-11-01T01:03:12.943416+00:00
Published At
2026-10-28T00:00:00+00:00
Record Updated At
2026-10-28
Source Retrieved At
2026-11-01T01:03:12.230707+00:00
Timestamp Basis
ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter
Date limitation
ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Myelodysplastic Syndromes (MDS)", "Leukemia Acute Myeloid - AML"]
protocolSection.statusModule.lastUpdatePostDateStruct
{"date": "2026-10-28", "type": "ACTUAL"}
protocolSection.identificationModule.nctId
"NCT06886425"
protocolSection.identificationModule.officialTitle
"Involvement of CDA and/or dCK Metabolizing Enzymes in the Response to Azacytidine Treatment of Patients With Hematologic Malignancies"
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
["NA"]
protocolSection.statusModule.resultsFirstPostDateStruct
null

Study condition terms

  • Myelodysplastic Syndromes (MDS) (protocolSection.conditionsModule.conditions)
  • Leukemia Acute Myeloid - AML (protocolSection.conditionsModule.conditions)

Interventions recorded in this study

  • {'armGroupLabels': ['Blood sampling'], 'description': 'Blood sampling :\n\nCure 1 before starting treatment Cure 3 before starting treatment Cure 6 after completion of treatment', 'name': 'genetic study', 'type': 'OTHER'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['Blood sampling'], 'description': 'Cure 1: after completion of subcutaneous administration of azacytidine A total of 5 samples in the induction phase.\n\nCure 3: after completion of subcutaneous administration of azacytidine A total of 5 samples in the induction phase.\n\nCure 6: after completion of subcutaneous administration of azacytidine A total of 5 samples in the induction phase.', 'name': 'Pharmacokinetic study', 'type': 'OTHER'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['Blood sampling'], 'description': 'Blood sampling :\n\nCure 1 before starting treatment Cure 3 before starting treatment Cure 6 after completion of treatment', 'name': 'Study of phenotypic activity of cytidine deaminase', 'type': 'OTHER'} (protocolSection.armsInterventionsModule.interventions[])

An intervention appearing in a study record does not establish an effect or an approved use.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.